Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.

AI drug creation company Absci Corporation (NASDAQ:ABSI) shares are trading higher in premarket on Wednesday after the ...

The deal expands a deal to discover and develop treatments for obesity, type 2 diabetes and cardiovascular disease using ...

The $20 million deal gives the chip supplier a toehold in the life-sciences market, a strategy it plans to replicate in other ...

Researchers at the University of Oklahoma have developed a breakthrough method of adding a single nitrogen atom to molecules, ...

With this model, researchers may be able to discover antibody drugs capable of targeting a wide range of infectious diseases.

This article provides examples of how AI is helping to shape drug discovery, from drug design through to clinical trials.

Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical ...

We recently published a list of 13 AI News and Ratings You Probably Missed. In this article, we are going to take a look at ...

Alloy Therapeutics ("Alloy"), a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug ...

Absci will use AMD’s $20 million investment to enhance its AI models. In parallel, the companies will collaborate to develop ...

Drug pricing is influenced by numerous factors, but technology has the potential to strike the critical balance between ...